Individualized Prophylaxis in Patients with Esophageal Replacement because of Cancer

Surgical Infections

Volumn 16, Issue 5, 2015, Pages 513-517

  Horáková, Martina ^a   Lubušká, Lucie ^a   Kolář, Milan ^b   Hricová, Kristýna ^b   Vrba, Radek ^a   Neoral, Cestmír ^a   Zapletalová, Jana ^b  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTAZIDIME; FLUCONAZOLE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BURKHOLDERIA CEPACIA COMPLEX; CANCER SURGERY; CANDIDA ALBICANS; CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SERRATIA MARCESCENS; SPUTUM ANALYSIS; SURGICAL INFECTION; BACTERIUM; CLASSIFICATION; ESOPHAGEAL NEOPLASMS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PERSONALIZED MEDICINE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; RESPIRATORY TRACT INFECTIONS; SPUTUM; TREATMENT OUTCOME;

ANTIBIOTIC PROPHYLAXIS; BACTERIA; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRECISION MEDICINE; PREOPERATIVE CARE; RESPIRATORY TRACT INFECTIONS; SPUTUM; TREATMENT OUTCOME;

EID: 84943746641     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2014.132     Document Type: Article

References (17)

1. Bakhos CT, Fabian T,Oyasiji TO, et al. Impact of the surgical technique on pulmonarymorbidity after esophagectomy. Ann Thorac Surg 2012;93:221-226.
2. Paul DJ, Jamieson GG, Watson DI, et al. Perioperative risk analysis for acute respiratory distress syndrome after elective oesophagectomy. ANZ J Surg 2011;81:700-706.
3. Ferguson MK, Celauro AD, Prachand V. Prediction of major pulmonary complications after esophagectomy. Ann Thorac Surg 2011;91:1494-1500.
4. Schieman C, Wigle DA, Deschamps C, et al. Patterns of operative mortality following esophagectomy. Dis Esophagus 2012;25:645-651.
5. Wright CD, Kucharczuk JC, O'Brien SM, et al. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg 2009;137:587-595.
6. Kusano C, Baba M, Tanabe G, et al. A study on the changes in the tracheo-bronchial mucosa after esophagectomy for esophageal cancer; with special reference to the influence of neck and upper mediastinal lymph node dissections. Nihon Geka Gakkai Zasshi 1989;90:1866-1872.
7. Fang W, Kato H, Tachimori Y, et al. Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer. Ann Thorac Surg 2003;76:903-908.
8. D'journo XB, Michelet P, Avaro JP, et al. Respiratory complications after oesophagectomy for cancer. Rev Mal Respir 2008;25:683-694.
9. Neoral C Horakova M, Aujesky R, et al. Infectious complications after esophagectomy. Surg Infect 2012;13:159-162.
10. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters www. eucast. org/clinical-breakpoints (Last accessed June 17, 2015).
11. Htoutou Sedlakova M, Hanulik V, Chroma M, et al. Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Med Sci Monit 2011;17: BR147-152.
12. Chroma M, Kolar M. Genetic methods for detection of antibiotic resistance: Focus on extended-spectrum b-lactamases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010;154:289-296.
13. Uvizl R, Hanulik V, Husickova V, et al. Hospital-acquired pneumonia in ICU patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011;155:373-378.
14. Arnan M, Gudiol C, Calatayud L, et al. Risk factors for, and clinical relevance of, faecal extended-spectrum b-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 2011;30:355-360.
15. Kolár M, Htoutou Sedláková M, Pudova P, et al. Incidence of fecal Enterobacteriaceae producing broad-spectrum beta-lactamases in patients with hematological malignancies. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:100-103.
16. Polk HC Jr, Lopez-Mayor JF. Postoperative wound infection: A prospective study of determinant factors and prevention. Surgery 1969;66:97-103.
17. Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg 2009;249:551-556.